questionsmedicales.fr
Technologie, industrie et agriculture
Produits manufacturés
Dispositifs pour fumer
Produits du tabac
Produits du tabac : Questions médicales fréquentes
Termes MeSH sélectionnés :
Social Communication Disorder
Diagnostic
2
Dépendance au tabac
Diagnostic médical
Tests de fonction pulmonaire
Tabagisme
Symptômes
2
Intoxication au tabac
Symptômes
Tabagisme
Maladies respiratoires
Prévention
2
Prévention du tabagisme
Éducation à la santé
Législation anti-tabac
Santé publique
Traitements
2
Sevrage tabagique
Traitement médicamenteux
Thérapie comportementale
Dépendance au tabac
Complications
2
Complications du tabagisme
Maladies cardiovasculaires
Cancer du poumon
Tabagisme
Facteurs de risque
2
Facteurs de risque
Tabagisme
Stress
Dépendance au tabac
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Produits du tabac : Questions médicales les plus fréquentes",
"headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-18",
"dateModified": "2025-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Produits du tabac"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dispositifs pour fumer",
"url": "https://questionsmedicales.fr/mesh/D000074602",
"about": {
"@type": "MedicalCondition",
"name": "Dispositifs pour fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tabac sans fumée",
"alternateName": "Tobacco, Smokeless",
"url": "https://questionsmedicales.fr/mesh/D014030",
"about": {
"@type": "MedicalCondition",
"name": "Tabac sans fumée",
"code": {
"@type": "MedicalCode",
"code": "D014030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"url": "https://questionsmedicales.fr/mesh/D000073846",
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"alternateName": "Tobacco Products",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takahiro Tabuchi",
"url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi",
"affiliation": {
"@type": "Organization",
"name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "Jennifer B Unger",
"url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America."
}
},
{
"@type": "Person",
"name": "Pamela M Ling",
"url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling",
"affiliation": {
"@type": "Organization",
"name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California."
}
},
{
"@type": "Person",
"name": "Silvano Gallus",
"url": "https://questionsmedicales.fr/author/Silvano%20Gallus",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy."
}
},
{
"@type": "Person",
"name": "Jessica L Barrington-Trimis",
"url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Usefulness of the autism spectrum quotient (AQ) in screening for autism spectrum disorder and social communication disorder.",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37957611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12888-023-05362-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing Pragmatic Language skills for Young children with Social communication difficulties (E-PLAYS-2) trial: study protocol for a cluster-randomised controlled trial evaluating a computerised intervention to promote communicative development and collaborative skills in young children.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38741221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40359-024-01749-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploratory Factor Analysis of the Social Communication Disorder Screener.",
"datePublished": "2023-08-29",
"url": "https://questionsmedicales.fr/article/37642878",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10803-023-06076-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence and functional impact of social (pragmatic) communication disorders.",
"datePublished": "2022-09-16",
"url": "https://questionsmedicales.fr/article/36114685",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jcpp.13705"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autism spectrum disorder, social pragmatic communication disorder, developmental language disorder- multimorbidity or mutual exclusivity?",
"datePublished": "2024-07-17",
"url": "https://questionsmedicales.fr/article/39032223",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajp.2024.104162"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Produits du tabac - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Produits du tabac",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Produits du tabac",
"description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Produits du tabac",
"description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Produits du tabac",
"description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Produits du tabac",
"description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Produits du tabac",
"description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Produits du tabac",
"description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Social+Communication+Disorder#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les effets du tabac ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication au tabac ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques."
}
},
{
"@type": "Question",
"name": "Comment le tabac affecte-t-il la respiration ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le tabagisme chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac sont-elles efficaces ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter de fumer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales sont-elles efficaces ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Le tabac augmente-t-il le risque de cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la consommation de tabac ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/02/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan.
Publications dans "Produits du tabac" :
4 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
4 publications dans cette catégorie
Affiliations :
Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
RAND Corporation, Pittsburgh, PA, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
RAND Corporation, Santa Monica, CA, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
School of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Oncologic Network, Prevention and Research Institute (ISPRO), 50139 Florence, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, United States.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
In the Diagnostic and Statistical Manual and Mental Disorders, Fifth Edition (DSM-5), autism spectrum disorder (ASD) and social (pragmatic) communication disorder (SCD) were described as a new categor...
Participants were 127 ASD patients, 52 SCD patients, and 49 NT individuals. Receiver operating characteristic (ROC) analyses were used to examine AQ-J total score cutoff values to distinguish between ...
In the ROC analysis for the ASD and NT groups, the area under the curve (AUC) was 0.96, and the optimum cutoff value was 23 points (sensitivity 92.9%, specificity 85.7%). The AUC for the SCD and NT gr...
Our findings suggest the usefulness of the AQ-J in screening for ASD and SCD....
A number of children experience difficulties with social communication and this has long-term deleterious effects on their mental health, social development and education. The E-PLAYS-2 study will tes...
The aim of the E-PLAYS-2 trial is to establish the effectiveness and cost-effectiveness of care as usual plus the E-PLAYS programme, delivered in primary schools, compared to care as usual. Cluster-ra...
The aim of this study is to undertake a final, definitive test of the effectiveness of E-PLAYS when delivered by teaching assistants within schools. The use of technology in game form is a novel appro...
ISRCTN 17561417, registration date 19th December 2022....
v1.1 19th June 2023....
Currently, there are no existing measures to screen for or diagnose Social (Pragmatic) Communication Disorder (SPCD). We conducted an exploratory factor analysis (EFA) of the Social Communication Diso...
The aim of this study was to evaluate the Children's Communication Checklist-2 (CCC-2) for measuring social-pragmatic communication deficits and to ascertain their prevalence and functional impact in ...
We used parent and teacher responses to the CCC-2 to approximate inclusion (poor social-pragmatic skills) and exclusion (poor structural language skills or autistic symptomatology) criteria for social...
Regardless of the diagnostic algorithm used, the resulting prevalence rates for social-pragmatic deficits indicated that very few children had isolated social-communication difficulties (0-1.3%). Howe...
A considerable proportion of children in the early years of primary school has social-pragmatic deficits that interfere with behaviour and scholastic activity; however, these rarely occur in isolation...
Diagnostic confusion commonly arises when assessing for social communicative dysfunction. Clinicians are tasked to differentiate ASD, social pragmatic disorder and developmental language disorders, wh...
The purpose of this study was to explore the communication and social interaction experiences of adolescents with congenital motor speech disorders due to cerebral palsy or Down syndrome, with the aim...
Five male youths (ages 14-18 years) with congenital motor speech disorders and one of their parents participated in face-to-face, semistructured interviews designed to understand communication and soc...
Participants described the youths' day-to-day communication experiences, including facilitators and barriers to successful social interactions. Thematic analysis revealed three main themes: (a) strong...
Participants reported that the impact of congenital motor speech disorders on social interactions and experiences became more apparent in adolescence than in earlier childhood. Addressing communicatio...
Social Communication Disorder (SCD), introduced in the DSM-5, is distinguished from Autism Spectrum Disorder (ASD) by the absence of restricted and repetitive behaviors or interests (RRBIs)....
To compare the adaptive, sensory, communication, and cognitive profiles of children with ASD and SCD....
The assessments of nine children with SCD and ten with ASD were compared with either Fisher's Exact Test or the Mann-Whitney Test. Assessments included the Vineland Adaptive Behavior Scales, the Autis...
The total ADOS score and the second subtotal "Restricted and Repetitive Behaviors" were significantly higher (...
While ASD and SCD share similarities in communication and pragmatic difficulties, some distinctions have been identified, e.g. in executive functioning and the impact on socialization, which may be li...
There are no assessment and screening tools for Autism Spectrum Disorders (ASD) validated for the Portuguese population. The Social Communication Questionnaire (SCQ) is an useful screening tool of ASD...
Neuroimaging studies of individuals with autism spectrum disorders (ASDs) consistently find an aberrant pattern of reduced laterality in brain networks that support functions related to social communi...
Autism spectrum disorder is characterized by social communication difficulties and social skills abilities that are significantly differ from neurotypical populations as well as restricted and repetit...